¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Positive clinical trial"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • clinical efficacy
    ÀÓ»óÈ¿´É
  • clinical epidemiologist
    ÀÓ»ó¿ªÇÐÀÚ
  • clinical epidemiology
    ÀÓ»ó¿ªÇÐ
  • clinical finding
    ÀÓ»ó¼Ò°ß
  • clinical laboratory
    ÀÓ»ó°Ë»ç½Ç
  • clinical manifestation
    ÀÓ»óÁõ»ó, ÀÓ»ó¼Ò°ß
  • clinical material
    Àӻ󰡰˹°, ÀÓ»ó°Ëü
  • clinical medicine
    ÀÓ»óÀÇÇÐ
  • clinical otosclerosis
    ¹ßÇö±Í°æÈ­Áõ
  • clinical pathology
    ÀÓ»óº´¸®ÇÐ
  • clinical record
    ÀÓ»ó±â·Ï
  • clinical root
    ÀÓ»óÄ¡¾Æ»Ñ¸®, ÀÓ»óÄ¡±Ù
  • clinical sign
    ÀÓ»ó¡ÈÄ
  • clinical significance
    ÀÓ»óÀûÁ߿伺
  • clinical skill
    ÀÓ»ó¼ú±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • clinical crown
    ÀÓ»óÄ¡¾Æ¸Ó¸®, ÀÓ»óÄ¡¾Æ°ü
  • clinical data
    ÀÓ»óÀÚ·á
  • clinical diagnosis
    ÀÓ»óÁø´Ü
  • clinical efficacy
    ÀÓ»óÈ¿´É
  • clinical epidemiologist
    ÀÓ»ó¿ªÇÐÀÚ
  • clinical epidemiology
    ÀÓ»ó¿ªÇÐ
  • clinical finding
    ÀÓ»ó¼Ò°ß
  • clinical laboratory
    ÀÓ»ó°Ë»ç½Ç
  • clinical manifestation
    ÀÓ»óÁõ»ó, ÀÓ»ó¼Ò°ß
  • clinical material
    Àӻ󰡰˹°, ÀÓ»ó°Ëü
  • clinical medicine
    ÀÓ»óÀÇÇÐ
  • clinical mycology
    ÀÓ»óÁø±ÕÇÐ
  • clinical otosclerosis
    ¹ßÇö±Í°æÈ­Áõ
  • clinical record
    ÀÓ»ó±â·Ï
  • clinical root
    ÀÓ»óÄ¡¾Æ»Ñ¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Rh positive
    Rh ¾ç¼º
  • SAPS, Scale for the Assessment of Positive Symptoms
    ¾ç¼ºÁõ»óÆò°¡Ã´µµ
  • gram positive organism
    ±×·¥¾ç¼º¼¼±Õ.
  • hallucination, positive
    ¾ç¼ºÈ¯°¢(åÕàõü³ÊÆ)
  • high frequency positive pressure ventilation =HFPPV
    °íºóµµ¾ç¾Ðȯ±â.
  • positive acceleration
    ¾ç°¡¼Óµµ(Çö»ó)(åÕÊ¥áÜöôúÞßÚ).
  • positive after image
    ¾ç¼ºÀÜ»ó(åÕàõíÑßÀ).
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • positive airway pressure
    ±âµµ¾ç¾Ð(ѨԳ åÕäâ).
  • positive balance
    ¾ç¼º¼öÁö.
  • positive charge
    ¾çÀüÇÏ(åÕï³ùÃ).
  • positive chronotropic
    ½É¹Úµ¿Áõ°¡.
  • positive chronotropy
    ½É¹Úµ¿¼öÃËÁø<Ç×Áø>(ÀÛ¿ë).
  • positive colloid
    ¾ç¼ºÄÝ·ÎÀ̵å, Á¤(ïá)ÄÝ·ÎÀ̵å.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • clinical clerk
    ÀÓ»ó¼­±â(ÊÙË×Ë»).
  • clinical correlation
    ÀÓ»óÀû »ó°ü°ü°è
  • clinical crib
    ÀÓ»ó¿ë À¯¾ÆÄ§´ë(¡­éÄêêä®öÖÓæ).
  • clinical crown
    ÀÓ»óÄ¡¾Æ°ü, ÀÓ»óÄ¡°ü(ìúßÉöÍή).
  • clinical crown
    ÀÓ»óÄ¡¾Æ¸Ó¸®
  • clinical crown
    ÀÓ»óÄ¡°ü(¡­öÍή).
  • clinical decision making
    ÀÓ»óÀû(ÀÎ) °áÁ¤
  • clinical dementia rating scale (CDRS)
    ÀÓ»óÀû Ä¡¸ÅÆò°¡(ìúßÉîÜ öÂØÜøÄʤ)ôµµ
  • clinical diabetes
    ÀÓ»ó(Àû) ´ç´¢º´ (¡­îÜÓØèñÜ»).
  • clinical diagnosis
    ÀÓ»ó(Àû) Áø´Ü(¡­òàÓ¨).
  • clinical effect
    ÀÓ»ó(Àû) È¿°ú
  • clinical efficacy
    ÀÓ»óÀûÀ¯È¿µµ, ÀÓ»óÀûÈ¿´É (À¯È¿¼º)
  • clinical finding
    ÀÓ»ó(Àû) ¼Ò°ß
  • clinical hematology
    ÀÓ»óÇ÷¾×ÇÐ(¡­úìäûùÊ).
  • clinical hematology
    ÀÓ»óÇ÷¾×ÇÐ(?Ì´Ëâ̰).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
CPTP culture-positive toxin-positive
PPV pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur...
ACTG AIDS Clinical Trial Group
CTC chlortetracycline; Clinical Trial Certificate; computed tomographic colography; computer-aided tomog...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CATCH Child and Adolescent Trial for Cardiovascular Health
CCTR Cochrane Controlled Trial Register
COMMIT Community Intervention Trial for Smoking Cessation
CAVEAT Coronary Angioplasty Versus Excisional Atherectomy Trial
DCCT Diabetes Control and Complication Trial
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • clinical research
    ÀÓ»ó ¿¬±¸
  • clinical resting position
    ÀÓ»óÀû ¾ÈÁ¤À§
  • clinical sign
    ÀÓ»ó ¡ÈÄ
  • clinical skill
    ÀÓ»ó ±â¼ú
  • clinical syndrome
    ÀÓ»ó ÁõÈıº, ÀÓ»óÀû ÁõÈıº
  • clinical unit
    ÀÓ»ó ´ÜÀ§
  • clinical-pathological correlation
    ÀÓ»ó-º´¸®ÇÐÀû »óÈ£°ü°è
  • controlled clinical study
    °ü¸®È­ ½ÃÇè, °ü¸®È­ ÀÓ»ó ½ÃÇè, Ãß°èÇÐÀû °ü¸®È­ ½ÃÇè, Ãß°èÇÐÀû °ü¸®È­ ÀÓ»ó ½ÃÇè
  • early clinical symptom
    Ãʱâ ÀÓ»ó Áõ»ó
  • lengthening of the clinical crown
    ÀÓ»ó Ä¡°ü ¿¬Àå¼ú
  • automatic intermittent positive pressure respirator
    ÀÚµ¿ °£ÇæÀû ¾ç¾Ð È£Èí±â
  • biologic false positive reaction
    »ý¹°ÇÐÀû °¡¾ç¼º ¹ÝÀÀ
  • chromatin-positive
    ¿°»öÁú ¾ç¼ºÀÇ
    »ó¿°»öü ¼¼Æ÷ ÇÙ¿¡ ¼º ¿°»öÁúÀ» °®°í ÀÖ´Â. Á¤»ó ¾ÏÄÆÀÇ Æ¯Â¡ÀÌ´Ù.
  • continuous positive airway pressure
    Áö¼Ó¼º ±âµµ ¾ç¾Ð
  • false positive reaction
    °¡¾ç¼º ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
open-label trial A study in which both researchers and participants know what drug a person is taking and at what dose.
(09 Oct 1997)
trial 1. The act of trying or testing in any manner. Specifically:
Any effort or exertion of strength for the purpose of ascertaining what can be done or effected. "[I] defy thee to the trial of mortal fight." (Milton)
The act of testing by experience; proof; test. "Repeated trials of the issues and events of actions." (Bp. Wilkins)
Examination by a test; experiment, as in chemistry, metallurgy, etc.
2. The state of being tried or tempted; exposure to suffering that tests strength, patience, faith, or the like; affliction or temptation that exercises and proves the graces or virtues of men. "Others had trial of cruel mockings and scourgings." (Heb. Xi. 36)
3. That which tries or afflicts; that which harasses; that which tries the character or principles; that which tempts to evil; as, his child's conduct was a sore trial. "Every station is exposed to some trials." (Rogers)
4. The formal examination of the matter in issue in a cause before a competent tribunal; the mode of determining a question of fact in a court of law; the examination, in legal form, of the facts in issue in a cause pending before a competent tribunal, for the purpose of determining such issue.
Synonym: Test, attempt, endeavor, effort, experiment, proof, essay. See Test, and Attempt.
Origin: From Try.
Source: Websters Dictionary
(01 Mar 1998)
trial and error The apparently random, haphazard, hit-or-miss exploratory activity which often precedes the acquisition of new information or adjustments; it may be overt, as in a rat running in a maze, or covert (vicarious), as when one thinks of various ways of coping with a situation.
(05 Mar 2000)
trial base <cell biology> A hypothetical cell adhesion molecule possibly involved in sponge cell adhesion, existence unproven.
(18 Nov 1997)
trial case In refraction, a box containing lenses for testing.
(05 Mar 2000)
trial denture A setup of artificial teeth so fabricated that it may be placed in the patient's mouth to verify esthetics, for the making of records, or for any other operation deemed necessary before final completion of the denture.
Synonym: wax model denture.
(05 Mar 2000)
trial frame A type of spectacle frame with variable adjustments, for holding trial lenses during refraction.
(05 Mar 2000)
trial lenses A series of cylindrical and spherical lens's used in testing vision.
(05 Mar 2000)
trial of labour Allowing a woman to be in labour long enough to determine if vaginal birth may be anticipated.
(12 Dec 1998)
CD4-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the t4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes, which includes both the helper-inducer (T-lymphocytes, helper-inducer) and suppressor-inducer (T-lymphocytes, suppressor-inducer) T-cells.
(12 Dec 1998)
CD8-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-lymphocytes, cytotoxic) and suppressor T-lymphocytes (T-lymphocytes, suppressor-effector).
(12 Dec 1998)
gram-positive <microbiology> Bacteria that retain the stain or that are resistant to decolourisation by alcohol during Gram's method of staining.
This is a primary characteristic of bacteria whose cell wall is composed of a thick layer of peptidologlycan containing teichoic and lipoteichoic acid complexed to the peptidoglycan.
See: gram-negative
(06 Oct 1997)
gram-positive asporogenous rods <microbiology> A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.
(12 Dec 1998)
gram-positive asporogenous rods, irregular <microbiology> A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores.
(12 Dec 1998)
gram-positive asporogenous rods, regular <microbiology> A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • trial marriage
    ½ÃÇè °áÈ¥(³²³à°¡ ÇÕÀÇÇÏ¿¡ ÀÏÁ¤±â°£ µ¿¼­ÇÏ´Â °ü°è)
  • trial run
    ½Ã¿îÀü;½Ã½Â
  • positive
    ¸í¹éÇÑ
  • Rh positive
    Rh ¾ç¼ºÀÇ Ç÷¾×(»ç¶÷)
  • Rh-positive
    (Ç÷¾×ÀÌ)Rh¾ç¼ºÀÇ;RhÀÎÀÚ°¡ ÀÖ´Â
  • positive
    È®½ÇÇÑ;¸íÈ®ÇÑ;È®½ÅÇÏ´Â;µ¶´ÜÀûÀÎ;¿ìÂáÇÑ;Àû±ØÀûÀÎ;Àý´ëÀûÀÎ;½ÇÀçÀÇ;¼øÀüÇÑ;¾çÀÇ;È®½ÇÈ÷;½ÇÁ¦;È®½Ç;¿ø±Þ;ÀüÁöÀÇ ¾ç±ØÆÇ;¾çÈ­;¾ç¼ö
  • positive charge
    ¾çÀüÇÏ
  • positive component
    Ç÷¯½º ¼ººÐ
  • positive electricity
    ¾çÀü±â
  • positive eugenics
    Àû±ØÀû ¿ì»ýÇÐ
  • positive euthanasis
    Àû±ØÀû ¾È¶ô»ç
  • positive growth
    Ç÷¯½º ¼ºÀå
  • positive ion
    ¾çÀÌ¿Â
  • positive law
    ½ÇÁ¤¹ý
  • positive lens
    Á¤·»Áî
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á